Table 1.
Eligibility and exclusion criteria of the study
Inclusion criteria |
- Age ≥ 45 years |
- Stage I-IIA histologically confirmed breast carcinoma |
- Tumor-free (at least 2 mm or more) inked histologic margins at surgical resection. |
Clinical exclusion criteria |
- Pregnancy |
- Collagen vascular disease |
- Aesthetic additive prostheses |
- Severe cardiac, pulmonary and liver diseases |
- Psychiatric illness compromising the correct acquisition of informed consent |
Oncologic exclusion criteria |
- Invasive lobular or multicentric carcinoma |
- Extensive associated non-invasive ductal carcinoma (synchronous or previous) |
- Peritumoral vascular invasion (> 3 vessels) |
- BRCA mutation carriers |
- More than 4 involved axillary lymph nodes |
- Distant metastasis |
- Non-epithelial malignancies of the breast |
- Synchronous contralateral invasive carcinoma |
- Paget disease, history of previous malignancy (except non-melanoma skin cancers and in situ oral cavity and cervix carcinoma) |